Antitumorigenic and antiangiogenic efficacy of apatinib in liver cancer evaluated by multimodality molecular imaging

Hepatocellular carcinoma (HCC) is one of the most common causes of cancer-related mortality worldwide. Sorafenib is the standard first-line treatment for advanced HCC, but its efficacy is limited. Apatinib is a small-molecule tyrosine kinase inhibitor that has shown promising antitumor effects in ga...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Qian, Kong, Lingxin, Du, Yang, Zhu, Xu, Tian, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802662/
https://www.ncbi.nlm.nih.gov/pubmed/31285418
http://dx.doi.org/10.1038/s12276-019-0274-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802662/
https://www.ncbi.nlm.nih.gov/pubmed/31285418
http://dx.doi.org/10.1038/s12276-019-0274-7

Ejemplares similares